Increased serum CA125 levels in plasma cell dyscrasias

Acta Haematologica

Volumn 98, Issue 2, 1997, Pages 104-108

  Iwasaki, Tsuyoshi ^a   Hamano, Teruaki ^a   Aizawa, Kaori ^a   Kobayashi, Kumiko ^a   Kakishita, Eizo ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

CA125; Extramedullary plasmacytoma; Plasma cell dyscrasia; Plasma cell leukemia

Indexed keywords

CA 125 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LAMBDA CHAIN; M PROTEIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CASE REPORT; CLINICAL PRACTICE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNORADIOMETRIC ASSAY; LYMPH NODE; MALE; MONONUCLEAR CELL; PLASMA CELL; PLASMA CELL DYSCRASIA; PLASMA CELL LEUKEMIA; PLASMACYTOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR CELL;

AGED; CA-125 ANTIGEN; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOGLOBULIN G; LEUKEMIA, PLASMACYTIC; LYMPH NODES; MALE; MIDDLE AGED; MUSCLE PROTEINS; MYELOMA PROTEINS; PARAPROTEINEMIAS; PLASMACYTOMA;

EID: 0030808176     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000203599     Document Type: Article

References (11)

1. Bast RC Jr. Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC: Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981:68:1331-1337.
2. Bast RC Jr., Klug TL., John ES RN, Jenison E, Niloff JM, Lazarus H., Berkowitz RS, Leavitt T, Griffiths T., Parker L., Zurawski VR Jr., Knapp RC: A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983:309:883-887.
3. Simonsson B, Kallander CFR, Brenning G, Killander A. Gronowitz JS, Bergstrom R, Ahre A: Biochemical markers in multiple myeloma: A multivariate analysis. Br J Haematol 1988; 69:47-53.
4. Bataille R, Jourdan M, Zahng X-G, Klein B: Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J Clin Invest 1989;84:2008-2011.
5. Ludwig H, Nachbaur DM, Fritz E, Krainer M. Huber H: Intcrleukin-6 is a prognostic factor in multiple myeloma. Blood 1991;77:2794-2795.
6. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T: Autocrine generation and requirement of BSF/IL-6 for human multiple myelomas. Nature 1988; 332:83-85.
7. Klein B., Zhang X-G., Jourdan M., Jourdan M, Content J, Houssiau F, Aardcn L, Piechaczyk M, Bataille R: Paracrine rather than autocrine regulation of myeloma cell growth and differentiation by interleukin-6. Blood 1989;73:517- 526.
8. Lichtenstein A, Bercnson J, Norman D, Chang MP, Carlile A: Production of cytokines by bone marrow cells obtained from patients with multiple myeloma. Blood 1989;73:517-526.
9. Hata H, Matsuzaki H. Tanaka K, Nomura H, Kagimoto T, Takeya M, Yamanc N, Takatsuki K: Ectopic production of salivary type amylase by a IgA-7.-typc multiple myeloma. Cancer 1988;62:1511-1515.
10. Matsuzaki H, Takatsuki K: Amylase producing multiple myeloma. Blood 1989,74:889.
11. Klug TL, Green PJ. Zurawski VR Jr, Davis HM: Confirmation of a false-positive result in CA125 immunoradiometric assay caused by human anti-idiotypic immunoglobulin. Clin Chem 1988;34:1071-1076.